FDA Approves Pfizer's NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency - Pfizer pfizer.com Submitted by pfizercom6279 on June 28, 2023 at 11:32 AM in business No comments 54